PERSPECTIVES
repressors of gene expression are perhaps not limited to miRNAs. Specific Piwi-interacting RNAs, thought to repress gene expression, may enhance transcription in the fly Drosophila melanogaster (6) . Moreover, when delivered into mammalian cells, some double-stranded RNAs complementary to promoter sequences increase gene expression (7, 8) .
The present work by Vasudevan et al. raises many questions. What are the mechanisms by which miRNAs enhance translation? Does miRNA stimulation of translation raise a possible complication, and opportunity, in using miRNAs and small interfering RNAs as therapeutics? Finally, assuming miRNAs generally stimulate translation in cells exiting the cell cycle, what role might miRNAs play in developmental and terminal differentiation processes? In a field replete with activity, this latest twist in function may foreshadow even more faces of these intriguing micromolecules.
I n 1985, Farman et al.
(1) discovered a substantial thinning of the stratospheric ozone layer over Antarctica in spring. This "ozone hole" took the atmospheric research community by surprise because it could not be explained by any catalytic cycles known to remove ozone in the stratosphere. Today, the consensus is that the chemical processes responsible for the formation of this "ozone hole" are reasonably well understood. New laboratory data published recently by Pope et al. (2) call this consensus into question, but the results must be treated with caution.
Two types of processes are key to understanding the unusually large ozone loss rates in the cold polar stratosphere. First, HCl and ClONO 2 are activated on the surfaces of polar stratospheric clouds to form compounds actively involved in catalytic ozone destruction (3) . Next, these activated species participate in the ClO-dimer (4) and ClO-BrO (5) catalytic cycles that rapidly destroy ozone at cold temperatures and high solar zenith angles. These two catalytic cycles are believed to be responsible for more than 80% of polar ozone loss during spring (6) .
The results published by Pope et al. (2) suggest a much smaller absorption cross section of the ClO dimer ClOOCl (see the left panel of the figure). The absorption cross section is a measure of how efficiently light is absorbed and determines how fast ClOOCl is photolyzed. This photolysis determines the speed of the ClO-dimer cycle and also affects the ClO-BrO cycle. The new result would make both cycles-and hence the overall ozone loss rate-much slower, with possible implications for our ability to predict future polar ozone depletion (7) .
In their experiment, Pope et al. (2) have introduced an innovative way to avoid impurities by trapping ClOOCl at -125°C before the absorption measurement. However, they did not present a detailed analysis of how possible systematic errors due to impurities may have affected earlier studies. For example, the difference between cross sections published by Burkholder et al. (8) and by Pope et al. cannot be explained by any linear combination of absorption spectra resulting from known impurities. Moreover, Pope et al. failed to add confidence to their results by monitoring infrared and/or microwave absorption as done in earlier studies (8) . Without these tests, the authors cannot completely rule out heterogeneous chemistry in the cold trap or secondary chemistry in the photolysis cell. This is particularly problematic because the interpretation of their data relies on the assumptions that the ClOOCl absorption spectrum is fully represented by the superposition of two Gaussian functions and that no impurities other than Cl 2 are present.
The challenges posed by the new study may act as an incentive to address the problem on a wider scale. The laboratory studies available today all disagree with each other, and only one-or maybe none-can be correct. To solve this dilemma, we must understand and unambiguously identify the reasons for the discrepancies.
Doubts about the correctness of the Pope et al. measurements are supported by the fact that they are at odds with a wealth of atmospheric observations suggesting larger cross sections (6, 9) . Most observations of ClO and its dimer-measured in situ and from satellitesare best explained by the cross sections published by Burkholder et al. (8) , which are the largest in the wavelength region relevant for photolysis in the atmosphere (see the right panel of the figure). These cross sections also best New laboratory data imply unknown mechanisms in the formation of the ozone hole, but it is too soon to throw out the old paradigms.
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The author is in the Institute for Chemistry and Dynamics of the Geosphere ICG-1: Stratosphere, Forschungszentrum Jülich GmbH, 52425 Juelich, Germany. E-mail: m.von. hobe@fz-juelich.de reproduce ozone loss in model simulations (6, 10 Given the observed close link between ozone loss and stratospheric chlorine (12, 13) , it seems very unlikely that chlorine compounds do not play the key role in destroying polar ozone and that the new measurements will compromise the Montreal Protocol on Substances That Deplete the Ozone Layer in any way (7) . Nevertheless, atmospheric scientists must explain both the substantial discrepancies between different laboratory studies of the ClOOCl cross sections and the discrepancies between atmospheric observations and laboratory data. Whether this will require introducing previously neglected chlorine species and modified ozone destruction mechanisms remains to be seen. PERSPECTIVES E ver since it was first suggested by Robert Edwards and Patrick Steptoe in their 1980 book A Matter of Life (1), it seemed that the path to making immunocompatible cells to potentially treat human diseases would necessitate cloning of a human embryo. This process calls for replacing the DNA of an unfertilized egg (oocyte) with that from the patient's somatic cell, in vitro culture of the reconstructed embryo to the blastocyst stage, and subsequent isolation of pluripotent cells that could potentially differentiate into any cell type. The prediction of Edwards and Steptoe came closer to reality with the arrival of Dolly, the cloned sheep, and derivation of the first human embryonic stem cells by James Thomson's group (2, 3) . This procedure of somatic cell nuclear transfer has been referred to as human therapeutic cloning (4) , and although studies in mice have shown that this approach is possible (5, 6) , its proof-of-principle in humans never materialized. Now, two reports in this issue-by Yu et al. on page 1917 (7) and Hanna et al. on page 1920 (8)-and a recent report by Takahashi et al. (9) suggest that human therapeutic cloning may never happen.
Takahashi et al. (9) report the generation of human induced pluripotent stem cells using four transcription factors: Oct4, Sox2, Klf4, and c-Myc. These are the same transcription factors previously reported by this group and others to produce such stem cells in mice (10) (11) (12) (13) (14) . Takahashi et al. have now shown that exogenous expression of these genes (delivered by retroviral vectors) can transform newborn and adult human fibroblasts into induced pluripotent stem cells. Two of these factors can be considered predictable in that they appear in most microarray analyses of mouse and human embryonic stem cells and are important in development. But the two other factors, c-Myc and Klf4, were unforeseen, and their presence in the "reprogramming quartet" in mice has been difficult to justify. Nevertheless, the cocktail works in human cells, and now the challenge is to determine each factor's role during the reversion of a mature cell to an earlier, unspecialized form that can then differentiate into multiple cell types.
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